Skip to main content

2 Result(s)

within Michinori Ogura Remove this filter English Remove this filter Pharmacology/Toxicology Remove this filter

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies

Include preview-only content

  1. Article

    Open Access

    A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan

    This phase I/II clinical study was conducted to examine the safety, tolerability, pharmacokinetics, and efficacy of 10-min dosing of bendamustine in patients with previously untreated indolent B-cell non-Hodgk...

    Kenichi Ishizawa, Masahiro Yokoyama, Harumi Kato… in Cancer Chemotherapy and Pharmacology (2022)

    Download PDF (787 KB) View Article

  2. Article

    Open Access

    Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia–lymphoma and peripheral T-cell lymphoma

    Natural killer (NK) cells are well known to be the most important effector cells mediating antibody-dependent cellular cytotoxicity (ADCC) which is an important mechanism of action of antibody drugs. We evalua...

    Michinori Ogura, Takashi Ishida, Kunihiro Tsukasaki… in Cancer Chemotherapy and Pharmacology (2016)

    Download PDF (1687 KB) View Article